This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aveyard, J. S. Articles by Knowles, M. A. Search for Related Content PubMed PubMed Citation Articles by Aveyard, J. S. Articles by Knowles, M. A.

JMD 2004, Vol. 6, No. 4
Copyright © 2004 American Society for Investigative Pathology & Association for Molecular Pathology

Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification

From the Cancer Research UK Clinical Centre, St. James’s University Hospital, Leeds, United Kingdom

Many tumors have large homozygous deletions of the CDKN2A locus (encoding p14^ARF and p16) and of CDKN2B (p15). Our aim was to determine which gene is the major target in bladder cancer. We used quantitative real-time PCR (RTQ-PCR) to determine copy number of p15, of p14^ARF exon 1ß, and p16 exon 2 in 22 tumor cell lines and 83 bladder tumors, some of which had been assessed previously by duplex PCR. Titration experiments showed that homozygous deletion could be detected in the presence of up to 30% normal DNA. Results for cell lines were compatible with previous cytogenetic analyses. Ten cell lines and 32 tumors (38.5%) had homozygous deletion of at least one target. Thirteen tumors (15.7%) had deletion of all three targets. Two tumors had deletion of p14^ARF exon 1ß alone and four of p16 exon 2 alone. RTQ-PCR detected more homozygous deletions than duplex PCR. Finally we used a multiplex ligation-dependent probe amplification kit to provide independent confirmation of results. We conclude that with appropriate controls RTQ-PCR is a sensitive and robust method to detect copy number changes in tumors even in the presence of contaminating normal cell DNA.

This article has been cited by other articles:

				W. Tam, M. Gomez, A. Chadburn, J. W. Lee, W. C. Chan, and D. M. Knowles Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas Blood, May 15, 2006; 107(10): 4090 - 4100. [Abstract] [Full Text] [PDF]

				E. J. Chapman, P. Harnden, P. Chambers, C. Johnston, and M. A. Knowles Comprehensive Analysis of CDKN2A Status in Microdissected Urothelial Cell Carcinoma Reveals Potential Haploinsufficiency, a High Frequency of Homozygous Co-deletion and Associations with Clinical Phenotype Clin. Cancer Res., August 15, 2005; 11(16): 5740 - 5747. [Abstract] [Full Text] [PDF]

				C. H. Holschneider, R. L. Baldwin, K. Tumber, C. Aoyama, and B. Y. Karlan The Fragile Histidine Triad Gene: A Molecular Link Between Cigarette Smoking and Cervical Cancer Clin. Cancer Res., August 15, 2005; 11(16): 5756 - 5763. [Abstract] [Full Text] [PDF]